摘要
目的研究血管性假性视乳头炎患者采用复方樟柳碱治疗的临床效果和安全性,为药物治疗血管性假性视乳头炎提供参考。方法选取2013年6月-2015年6月我院收治的血管性假性视乳头炎患者132例为观察对象,根据治疗方式分为观察组与对照组各66例,对照组采用常规药物治疗,观察组在对照组基础上每天注射复方樟柳碱注射液,对比两组治疗前后的视野变化、治疗安全性及疗效。结果两组患者治疗后视野均有改善,但观察组治疗后视野改变明显大于对照组;观察组痊愈率和总有效率分别为39.51%和88.89%,显著高于对照组的24.36%和73.08%,观察组疗效更好。观察组治疗过程及治疗后不良反应总发生率为10.61%,显著小于对照组的24.24%,安全性更高。结论复方樟柳碱在治疗血管性假性视乳头炎中,疗效更佳,安全性较好,能够明显提高患者视力。
Objective To study of vascular false as the clinical effect and safety of acromastitis were treated by compound anisodine treatment,to provide reference for the treatment of vascular pseudo optic. Methods From June 2013 to June 2015,132 cases of patients with vascular pseudo optic papilla in our hospital were selected as the observation objects,and were divided into observation group and control group each 66 cases according to the treatment method. The control group was treated with routine drug therapy,and the observation group in the control group on the basis of daily injections of Compound Anisodine Hydrobromide Injection. Two groups before and after the treatment of vision changes,and the treatment of safety and efficacy were compared. Results The curative effect： The two groups of patients after treatment were improved,but the observation group was significantly higher than the control group after treatment; The cure rate and total effective rate of the observation group were 39. 51% and 88. 89% respectively,which was significantly higher than the control group of 24.36% and 73. 08%,and had better curative effect in observation group. Security aspect： The total incidence of adverse reactions in the observation group and the treatment group was 10. 61%,significantly less than 24. 24% of the control group,higher safety. Conclusion In the treatment of vascular pseudoaneurysms as papillitis drugs,the curative effect of compound anisodine is much better with better security,which can significantly improve the visual acuity of the patients.
出处
《现代医院》
2016年第10期1452-1454,共3页
Modern Hospitals
关键词
复方樟柳碱
糖尿病
血管性假性视乳头炎
Compound Anisodine
Diabetes Mellitus
Vascular Pseudo Papillitis
